Femasys (NASDAQ:FEMY) Trading 0.1% Higher – Time to Buy?

Femasys Inc. (NASDAQ:FEMY)’s share price rose 0.1% on Monday . The company traded as high as $0.60 and last traded at $0.5948. 629,160 shares were traded during trading, a decline of 52% from the average session volume of 1,300,342 shares. The stock had previously closed at $0.5943.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Laidlaw started coverage on Femasys in a research note on Thursday, November 20th. They issued a “buy” rating and a $6.50 price objective on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Femasys in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered Femasys from a “hold” rating to a “sell” rating in a report on Saturday, December 20th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $6.83.

Femasys Trading Up 0.1%

The company has a quick ratio of 0.61, a current ratio of 1.16 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $34.78 million, a price-to-earnings ratio of -0.83 and a beta of -2.54. The business has a 50-day moving average of $0.80 and a two-hundred day moving average of $0.70.

Femasys (NASDAQ:FEMY) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. Femasys had a negative return on equity of 764.26% and a negative net margin of 960.80%.The company had revenue of $0.73 million during the quarter, compared to the consensus estimate of $1.35 million. Research analysts predict that Femasys Inc. will post -0.86 EPS for the current fiscal year.

Institutional Investors Weigh In On Femasys

A number of institutional investors have recently bought and sold shares of FEMY. Jane Street Group LLC acquired a new position in shares of Femasys in the 2nd quarter valued at $82,000. Osaic Holdings Inc. acquired a new stake in shares of Femasys during the 2nd quarter valued at about $45,000. Finally, Clear Creek Financial Management LLC increased its stake in Femasys by 4.2% in the second quarter. Clear Creek Financial Management LLC now owns 281,821 shares of the company’s stock valued at $272,000 after acquiring an additional 11,450 shares during the period. Institutional investors and hedge funds own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.